View Item 

Show simple item record

The natural history of thin melanoma and the utility of sentinel lymph node biopsy

dc.contributor.authorDurham, Alison B.
dc.contributor.authorSchwartz, Jennifer L.
dc.contributor.authorLowe, Lori
dc.contributor.authorZhao, Lili
dc.contributor.authorJohnson, Andrew G.
dc.contributor.authorHarms, Kelly L.
dc.contributor.authorBichakjian, Christopher K.
dc.contributor.authorOrsini, Amy P.
dc.contributor.authorMcLean, Scott A.
dc.contributor.authorBradford, Carol R.
dc.contributor.authorCohen, Mark S.
dc.contributor.authorJohnson, Timothy M.
dc.contributor.authorSabel, Michael S.
dc.contributor.authorWong, Sandra L.
dc.date.accessioned2018-02-05T16:28:51Z
dc.date.available2019-01-07T18:34:39Zen
dc.date.issued2017-12
dc.identifier.citationDurham, Alison B.; Schwartz, Jennifer L.; Lowe, Lori; Zhao, Lili; Johnson, Andrew G.; Harms, Kelly L.; Bichakjian, Christopher K.; Orsini, Amy P.; McLean, Scott A.; Bradford, Carol R.; Cohen, Mark S.; Johnson, Timothy M.; Sabel, Michael S.; Wong, Sandra L. (2017). "The natural history of thin melanoma and the utility of sentinel lymph node biopsy." Journal of Surgical Oncology 116(8): 1185-1192.
dc.identifier.issn0022-4790
dc.identifier.issn1096-9098
dc.identifier.urihttps://hdl.handle.net/2027.42/141184
dc.publisherWiley Periodicals, Inc.
dc.publisherSpringer Science + Business Media
dc.subject.othermelanoma
dc.subject.otherthin melanoma
dc.subject.othersentinel lymph node biopsy
dc.titleThe natural history of thin melanoma and the utility of sentinel lymph node biopsy
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelSurgery and Anesthesiology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141184/1/jso24765_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141184/2/jso24765.pdf
dc.identifier.doi10.1002/jso.24765
dc.identifier.sourceJournal of Surgical Oncology
dc.identifier.citedreferenceMurali R, Haydu LE, Quinn MJ, et al. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Ann Surg. 2012; 255: 128 – 133.
dc.identifier.citedreferenceCooper C, Wayne JD, Damstetter EM, et al. A 10‐year, single‐institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas. J Am Acad Dermatol. 2013; 69: 693 – 699.
dc.identifier.citedreferenceAndtbacka RH, Gershenwald JE. Role of sentinel lymph node biopsy in patients with thin melanoma. J Natl Compr Canc Netw. 2009; 7: 308 – 317.
dc.identifier.citedreferenceMorton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992; 127: 392 – 399.
dc.identifier.citedreferenceGarbe C, Hauschild A, Volkenandt M, et al. Evidence and interdisciplinary consensus‐based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res. 2008; 18: 61 – 67.
dc.identifier.citedreferenceBichakjian CK, Halpern AC, Johnson TM, et al. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol. 2011; 65: 1032 – 1047.
dc.identifier.citedreferenceWong SL, Balch CM, Hurley P, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Ann Surg Oncol. 2012; 19: 3313 – 3324.
dc.identifier.citedreferenceCoit DG. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). 2016; Melanoma. Version I. 2016.
dc.identifier.citedreferenceMorton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel‐node biopsy versus nodal observation in melanoma. N Engl J Med. 2014; 370: 599 – 609.
dc.identifier.citedreferenceDurham AB, Wong SL. Sentinel lymph node biopsy in melanoma: controversies and current guidelines. Future Oncol. 2014; 10: 429 – 442.
dc.identifier.citedreferenceCordeiro E, Gervais MK, Shah PS, Look Hong NJ, Wright FC. Sentinel lymph node biopsy in thin cutaneous melanoma: a systematic review and meta‐analysis. Ann Surg Oncol. 2016; 23: 4178 –4188.
dc.identifier.citedreferenceVermeeren L, Van der Ent F, Sastrowijoto P, Hulsewe K. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value. Eur J Dermatol. 2010; 20: 30 – 34.
dc.identifier.citedreferenceVenna SS, Thummala S, Nosrati M, et al. Analysis of sentinel lymph node positivity in patients with thin primary melanoma. J Am Acad Dermatol. 2013; 68: 560 – 567.
dc.identifier.citedreferenceMozzillo N, Pennacchioli E, Gandini S, et al. Sentinel node biopsy in thin and thick melanoma. Ann Surg Oncol. 2013; 20: 2780 – 2786.
dc.identifier.citedreferenceWong SL, Brady MS, Busam KJ, Coit DG. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol. 2006; 13: 302 – 309.
dc.identifier.citedreferenceRanieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ, 3rd. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol. 2006; 13: 927 – 932.
dc.identifier.citedreferenceOliveira Filho RS, Ferreira LM, Biasi LJ, Enokihara MM, Paiva GR, Wagner J. Vertical growth phase and positive sentinel node in thin melanoma. Braz J Med Biol Res. 2003; 36: 347 – 350.
dc.identifier.citedreferenceOlah J, Gyulai R, Korom I, Varga E, Dobozy A. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas. Br J Dermatol. 2003; 149: 662 – 663.
dc.identifier.citedreferenceStatius Muller MG, van Leeuwen PA, van Diest PJ, Vuylsteke RJ, Pijpers R, Meijer S. No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res. 2001; 11: 303 – 307.
dc.identifier.citedreferenceKesmodel SB, Karakousis GC, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol. 2005; 12: 449 – 458.
dc.identifier.citedreferenceBleicher RJ, Essner R, Foshag LJ, Wanek LA, Morton DL. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol. 2003; 21: 1326 – 1331.
dc.identifier.citedreferenceWright BE, Scheri RP, Ye X, et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008; 143: 892 – 899, discussion 9–900.
dc.identifier.citedreferenceKoshenkov VP, Shulkin D, Bustami R, Chevinsky AH, Whitman ED. Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsy. J Surg Oncol. 2012; 106: 363 – 368.
dc.identifier.citedreferenceSondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol. 2004; 11: 247 – 258.
dc.identifier.citedreferenceCoit D. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Version I. 2017.
dc.identifier.citedreferenceSmoller BR. Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol. 2006; 19: S34 – S40.
dc.identifier.citedreferenceGhaferi AA, Wong SL, Johnson TM, et al. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol. 2009; 16: 2978 – 2984.
dc.identifier.citedreferenceAchkar T, Tarhini AA. The use of immunotherapy in the treatment of melanoma. J Hematol Oncol. 2017; 10: 88.
dc.identifier.citedreferenceGershenwald JE, Scolyer RA, Hess KR, et al. AJCC cancer staging manual. New York, NY: Springer Science + Business Media; 2016.
dc.identifier.citedreferenceKarakousis G, Gimotty PA, Bartlett EK, et al. Thin melanoma with nodal involvement: analysis of demographic, pathologic, and treatment factors with regard to prognosis. Ann Surg Oncol. 2017; 24: 952 –959.
dc.identifier.citedreferenceMorton DL. Overview and update of the phase III multicenter selective lymphadenectomy trials (MSLT‐I and MSLT‐II) in melanoma. Clin Exp Metastasis. 2012; 29: 699 – 706.
dc.identifier.citedreferenceBalch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27: 6199 – 6206.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jso24765_am.pdf
Size:
283.2KB
Format:
PDF
View/Open
Name:
jso24765.pdf
Size:
390.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.